CRISPR, a Crossroads in Genetic Intervention: Pitting the Right to Health against the Right to Disability.
Reproductive genetic technologies (RGTs), including gene-editing technology, are being discovered and refined at an exponential pace. One gene-editing innovation that demands our swift attention is CRISPR/Cas9, a system of clustered regularly interspaced short palindromic repeats and a protein called Cas9. As CRISPR and other RGTs continue being developed, we must remain vigilant concerning the potential implications of genetic-engineering technology on our interpersonal and legal relationships. In the face of increasingly numerous and refined RGTs, we must maintain the rights of everyone: potential parents, prospective children, and individuals (both living and prospective) with disabilities. For those who wish to become parents, how should procreation be regulated in light of developing RGTs, especially gene-editing technology? What duties do parents owe their children, and when does such a duty attach? What role should RGTs play in parents' fulfillment of their duties to their children? This article will contextualize the right to health and what I will term the "right to disability" in the CRISPR/Cas9 landscape. The article will then explore these rights in reference to the "subjunctive-threshold" interpretation of harm. Finally, I will argue that RGTs must be thoughtfully regulated, with such regulations taking into account the opinions of geneticists, bioethicists, and lay people concerning both the right to health and the right to disability.
Center for Research on Ethical, Legal and Social Implications of Psychiatric, Neurologic & Behavioral Genetics, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA.
Shawna
S
Benston
ADA; CRISPR; CRISPR/Cas9; disability; disability rights; gene-editing technology; genetics; genome-editing technology; law
Hastings Cent Rep. 2015 Sep-Oct;45(5):11-4
26413760
Hong Kong Med J. 2015 Aug;21(4):296-7
26238130
Science. 2015 Apr 3;348(6230):36-8
25791083
Bioethics. 2001 Oct;15(5-6):413-26
12058767
Prenat Diagn. 2010 Aug;30(8):771-7
20661891
JAMA. 2015 Jun 9;313(22):2225-6
26057280
Eur J Health Law. 2007 Nov;14(3):281-98
18348362
Am J Public Health. 1999 Nov;89(11):1649-57
10553384
Bioethics. 1993 Apr;7(2-3):178-87
11651530
Nature. 2015 Mar 26;519(7544):410-1
25810189
J Med Ethics. 2010 Apr;36(4):217-21
20338932
Am J Bioeth. 2009 Jan;9(1):36-43
19132621
Ann N Y Acad Sci. 2000 Sep;913:209-17
11040840
Science. 2014 Nov 28;346(6213):1258096
25430774
J Clin Med. 2014 Jun 20;3(2):632-45
26237394